APR 10, 2020 3:26 PM PDT

Cardiac Patch Repairs Heart Attack Damage in Pigs and Rats

WRITTEN BY: Annie Lennon

Heart attacks significantly damage cardiac tissue. Recovery time frames from a heart attack thus depend on the extent to which they damage cardiac tissue, as well as the availability and efficacy of any aids capable of accelerating the process. Now, researchers from North Carolina State University have developed a cardiac patch that is both effective in animal models, and that overcomes many of the dangers of other approaches. 

Although cardiac patches already exist as a treatment for heart attack-caused tissue damage, current options are fragile, costly and time-consuming to prepare. Moreover, as they make use of live cellular material, they also carry a heightened risk of inducing tumor formation and arrhythmia. 

“We have developed an artificial cardiac patch that can potentially solve the problems associated with using live cells, yet still deliver effective cell therapy to the site of injury,” says author of the study, Ke Cheng. 

The cardiac patch designed by the researchers consists of a scaffolding matrix made out of decellularized pig heart tissue. Biodegradable synthetic cardiac stromal cells with repair factors derived from real cardiac stromal cells are also embedded in the matrix. The patch’s design means that it is able to mimic cells that normally secrete therapeutics that repair heart tissue. 

Trials thus far have been successful. When experimenting with the patch on rats following an induced heart attack, the researchers found that it was able to improve their cardiac function by around 50% within three weeks in comparison to a control group not receiving treatment. They also noted that scarring was reduced by roughly 30%. Meanwhile, results from a pig model found that the patch was able to reduce scarring by 30% while stabilizing heart function compared to those who were left untreated. 

Further experiments also showed that the patches can still be used after having been frozen for at least a month. Cheng says, “The patch can be frozen and safely stored for at least 30 days, and since there are no live cells involved, it will not trigger a patient's immune system to reject it...It is a first step toward a truly off-the-shelf solution to cardiac patch therapy."


Sources: Science Daily, Interesting Engineering 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
SEP 21, 2020
Drug Discovery & Development
WHO Endorses Clinical Trials for Herbal Medicines to Treat COVID-19
SEP 21, 2020
WHO Endorses Clinical Trials for Herbal Medicines to Treat COVID-19
The World Health Organization has endorsed a protocol to put African herbal medicines through clinical trials as possibl ...
OCT 12, 2020
Drug Discovery & Development
In vitro glycoengineering - Suitability for BioPharma manufacturing
OCT 12, 2020
In vitro glycoengineering - Suitability for BioPharma manufacturing
Introduction The importance of Fc glycosylation of monoclonal antibodies (mAbs) with regard to biological activity is wi ...
OCT 12, 2020
Cancer
Targeting Energy Production in Cells to Fight Leukemia
OCT 12, 2020
Targeting Energy Production in Cells to Fight Leukemia
Much like how a car needs gasoline to run, cells also need a fuel source. Most human cells in the body use oxidative pho ...
OCT 27, 2020
Cardiology
Boron Could Prevent Myocardial Fibrosis and Assist in Recovery
OCT 27, 2020
Boron Could Prevent Myocardial Fibrosis and Assist in Recovery
When you pass by the nutrition section at the local grocery store, there is a chance you’ll come across row upon r ...
NOV 15, 2020
Drug Discovery & Development
Drug Stimulates Female Fertility
NOV 15, 2020
Drug Stimulates Female Fertility
A recent drug, MVT-602, was found to stimulate fertility by acting on the natural 'kisspeptin' hormone system in ...
NOV 24, 2020
Drug Discovery & Development
MMR Vaccine Shows Promise Against COVID-19
NOV 24, 2020
MMR Vaccine Shows Promise Against COVID-19
Researchers have found that a vaccine used for mumps, measles, and rubella (MMR) may be effective in protecting against ...
Loading Comments...